REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 159 filers reported holding REVANCE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,228,609 | $59,972,145 | 5.67% |
| Essex Woodlands Management, Inc. | 457,085 | $5,242,765 | 4.62% |
| Ghost Tree Capital, LLC | 350,000 | $4,014,500 | 1.32% |
| AlphaCentric Advisors LLC | 190,000 | $2,179,300 | 1.24% |
| Sio Capital Management, LLC | 342,477 | $3,928,211 | 1.22% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 288,726 | $3,308,800 | 1.12% |
| Rubric Capital Management LP | 1,600,000 | $18,352,000 | 0.69% |
| RICE HALL JAMES & ASSOCIATES, LLC | 683,937 | $7,844,757 | 0.50% |
| Rhenman & Partners Asset Management AB | 361,679 | $4,148,458 | 0.45% |
| Polar Capital Holdings Plc | 4,160,311 | $47,718,767 | 0.35% |